Patients receiving early and rapid intensification of oral HF treatment with angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) or ARNI, beta‐blockers, and MRAs showed a significant better outcome without safety concerns.10 Here, ACE is linked to hydrops fetalis.